Result Type

You Searched For: mycoplasma+detection

231  results were found

Mycoplasma: Detection & Elimination

Mycoplasma: Detection & Elimination Mycoplasma in Cell Culture Contamination of cell lines with mycoplasma is a widespread and often underestimated problem. Although visible signs like turbidity or pH-changes are rare mycoplasma infections can cau...

Contamination Prevention & Detection

Contamination Prevention & Detection Featured Solutions PanReac AppliChem offers a variety of solutions for prevention detection and fighting against cell culture contamination. Mycoplasma: detection & elimination Antibiotics & Antimycotics Additi...

Final fill for gene therapy

Final fill for gene therapy Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an...

Downstream purification for gene therapy

Downstream purification for gene therapy With more than 30 years of chromatography experience developed products and services we have every solution to meet your needs. Our J.T.Baker® brand BAKERBOND™ chromatography resins have been used successfu...

product information

product information 1 PCR Mycoplasma Test Kit Ready-to-use PCR Mix for the detection of Mycoplasma in Cell Culture Product-No. A3744 Introduction The PCR Mycoplasma Test Kit is designed to detect the presence of Mycoplasma contaminating biological...

Final fill for cell therapy

Final fill for cell therapy The cell therapy drug product is configured in different ways depending on the required delivery of the cells/tissues. For example delivery of chondrocytes for cartilage repair is administered by an injection. Expanded ...

Assays for final fill

Assays for final fill Assays The reduction of microbial (bacterial and fungal) endotoxin mycoplasma and virus contamination is extremely critical to ensure the quality of the drug substance and the quality and safety of the drug product. It is rou...

Final fill for mAbs

Final fill for mAbs Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO Cla...

Final fill for recombinant proteins

Final fill for recombinant proteins Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepar...

Downstream purification for vaccines

Downstream purification for vaccines During subsequent steps for vaccine concentration and clarification followed by passage through several filtration steps and chromatography columns it is critical that vaccine purity potency and consistency be ...

Final fill for vaccines

Final fill for vaccines Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO...

Downstream purification for recombinant proteins

Downstream purification for recombinant proteins With more than 30 years of chromatography experience developed products and services we have every solution to meet your needs. Our J.T.Baker® brand BAKERBOND™ chromatography resins have been used s...

PanReac Applichem Decontamination

PanReac Applichem Decontamination Decontamination and Control Reagents It is important to work clean as contamination is very frustrating for the scientist and in the end also very expensive. PanReac AppliChem offers a variety of products for prev...

Upstream processing for mAbs

Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...

Upstream processing for cell therapy

Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...

Upstream processing for microbial-based recombinant proteins

Upstream processing for microbial-based recombinant proteins Using microbial fermentation for the development and manufacture of recombinant proteins keeps on showing advantages e.g for the expression of proteins that do not require post-translati...
1 - 16 of 231